Healthcare / Medical - PharmaceuticalsUpdated 2026-05-10 22:07 UTC

LON/0RD1 stock hub

LON/0RD1 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

LON/0RD1is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

2.6B

London Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

LON/0RD1

In the news

Latest news · LON/0RD1

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E40.6

P25 12.9P50 16.9P75 23.5

Trailing P/E44.7

P25 15.9P50 22.9P75 35.8

ROE19.5

P25 -54.2P50 2.1P75 13.7

ROIC105.4

P25 -38.1P50 3.3P75 11.9

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All LON/0RD1 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

214

Groups with data

Currency

SEK

Showing 214 of 214 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Sweden
Country code	UK
Employees	274
Employees Change	55%
Employees Change Percent	24.44
Enterprise value	SEK 2.4B
Exchange	London Stock Exchange
Financial currency	SEK
First seen	2026-05-10
Industry	Medical - Pharmaceuticals
Isin	SE0007692850
Last refreshed	2026-05-10
Market cap	SEK 2.6B
Price	SEK 558
Price currency	SEK
Rev Per Employee	666,465.33x
Sector	Healthcare
Sic	2834
Symbol	lon/0RD1
Website	https://www.camurus.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	2.24%
EV Earnings	39.8x
EV/EBIT	33.51x
EV/EBITDA	32.65x
EV/FCF	40.03x
EV/Sales	13.09x
FCF yield	2.23%
Forward P/E	40.61x
P/B ratio	7.76x
P/E ratio	44.66x
P/S ratio	14.5x
PE Ratio3 Y	75.53x
PE Ratio5 Y	118.64x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	39.07%
EBITDA Margin	39.33%
FCF margin	32.29%
Gross margin	93.11%
Gross Profit	SEK 170M
Gross Profit Growth	21.36%
Gross Profit Growth Q	-17.65%
Gross Profit Growth3 Y	35.22%
Gross Profit Growth5 Y	47.64%
Net Income	SEK 59.3M
Net Income Growth	71.7%
Net Income Growth Q	-31.37%
Net Income Growth Years	1%
Net Income Growth3 Y	136.58%
Pretax Margin	41.19%
Profit Margin	32.47%
Profit Per Employee	SEK 216,401
Profitable Years	4
ROA	13.02
Roa5y	8.23
ROCE	20.24
ROE	19.55
Roe5y	13.5
ROIC	105.4
Roic5y	63.11

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	24.92%
Cagr1y	-15.46%
Cagr3y	30.96%
Cagr5y	22.68%
EPS Growth	70.28
EPS Growth Q	-32.01
EPS Growth Years	1
EPS Growth3 Y	132.9
FCF Growth	102.96%
FCF Growth Q	149%
FCF Growth3 Y	94.57%
OCF Growth	124.05%
OCF Growth Q	147.39%
OCF Growth3 Y	104.8%
Revenue Growth	21.3x
Revenue Growth Q	-16.03x
Revenue Growth Years	7x
Revenue Growth3 Y	33.3x
Revenue Growth5 Y	46.47x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	SEK 0.53
Assets	SEK 382.1M
Cash	SEK 300.3M
Current Assets	SEK 353.2M
Current Liabilities	SEK 29.2M
Debt	SEK 8.5M
Debt EBITDA	SEK 0.12
Debt Equity	SEK 0.03
Debt FCF	SEK 0.14
Equity	SEK 341.4M
Interest Coverage	156.7
Liabilities	SEK 40.7M
Long Term Assets	SEK 28.9M
Long Term Liabilities	SEK 11.4M
Net Cash	SEK 291.8M
Net Cash By Market Cap	SEK 11.02
Net Cash Growth	27.66%
Net Debt EBITDA	SEK -4.06
Net Debt Equity	SEK -0.85
Net Debt FCF	SEK -4.95
Tangible Book Value	SEK 341.4M
Tangible Book Value Per Share	SEK 5.75
WACC	6.98

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	12.09
Inventory Turnover	1.24
Net Working Capital	SEK 29.4M
Quick ratio	11.67
Working Capital	SEK 328.1M
Working Capital Turnover	SEK 0.05

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.85%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	824.83%
1Y total return	-15.45%
200-day SMA	614.3
3Y total return	124.63%
50-day SMA	503
50-day SMA vs 200-day SMA	50under200
5Y total return	177.83%
All Time High	749
All Time High Change	-25.5%
All Time High Date	2025-09-11
All Time Low	62.9
All Time Low Change	787.19%
All Time Low Date	2019-01-16
ATR	17.2
Beta	0.5
Ch YTD	-9.56
High	564.5
High52	749
High52 Date	2025-09-11
High52ch	-25.5%
Low	548.5
Low52	433
Low52 Date	2026-03-23
Low52ch	28.88%
Ma50ch	10.94%
Price vs 200-day SMA	-9.16%
RSI	60.73
RSI Monthly	50.34
RSI Weekly	48.29
Sharpe ratio	-0.2x
Sortino ratio	-0.18
Total Return	-0.85%
Tr YTD	-9.56
Tr1m	16.76%
Tr1w	1.5%
Tr3m	-18.53%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	SEK 71.4M
Operating Income Growth	90.92
Operating Income Growth Q	-22.75
Operating Income Growth3 Y	131.6
Operating margin	39.07

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	36,801,735%
Net Borrowing	-1,441,764.9
Shares Insiders	3.24%
Shares Institutions	35.6%
Shares Qo Q	0%
Shares Yo Y	0.85%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	SEK 59.2M
Average Volume	8,195x
Bv Per Share	5.75
CAPEX	SEK -11.1M
Ch10y	746.7
Ch1m	16.76
Ch1w	1.5
Ch1y	-15.45
Ch3m	-18.53
Ch3y	124.6
Ch5y	177.8
Ch6m	1.08
Change	-0.79%
Change From Open	-1.14
Close	562.5
Days Gap	0.36
Depreciation Amortization	458,938.7
Dollar Volume	4,537,993
Earnings Date	2026-04-29
EBIT	SEK 71.4M
EBITDA	SEK 71.8M
EPS	SEK 0.99
F Score	6
FCF	SEK 59M
FCF EV Yield	2.5x
Financing CF	12,760,278
Fiscal Year End	December
Founded	1,991
Graham Number	142.22389
Graham Upside	-74.51
Income Tax	SEK 15.9M
Investing CF	-11,166,382
Is Primary Listing	0
Last Earnings Date	2026-04-29
Last Report Date	2025-12-31
Lynch Fair Value	SEK 312
Lynch Upside	-44.02
Ma150	588.6
Ma150ch	-5.18%
Ma20	547.2
Ma20ch	1.98%
Net CF	70,393,894
Next Earnings Date	2026-05-12
Open	564.5
P FCF Ratio	44.91
P OCF Ratio	37.79
Position In Range	59.63
Ppne	22,193,420.9
Price Date	2026-05-08
Price EBITDA	SEK 36.87
Ptbv Ratio	7.76
Relative Volume	0.99x
Revenue	182,611,500x
SBC By Revenue	-0.11x
Share Based Comp	-208,618
Tax By Revenue	8.72x
Tax Rate	21.17%
Tr6m	1.08%
Volume	8,132
Z Score	46.37

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does LON/0RD1 pay a dividend?

Capital-return profile for this ticker.

Performance

LON/0RD1 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns LON/0RD1?

Insider, institutional, and short-interest positioning.

Institutional ownership

+35.6%

Share of float held by funds and institutions

Insider ownership

+3.2%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+0.9%

Negative means the company is buying back shares.

Technical

LON/0RD1 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

60.7

Neutral momentum band

Price vs 200-day MA

-9.2%

50/200-day relationship not available

Beta (5Y)

0.50

Less volatile than the market

Sharpe ratio

-0.20

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About LON/0RD1

Hub-level FAQ points readers to the deeper analysis pages.

What is the current lon/0RD1 stock rating?

lon/0RD1 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full lon/0RD1 analysis?

The full report lives at /stocks/lon/0RD1/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for lon/0RD1?

The latest report frames lon/0RD1 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the lon/0RD1 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.